CURA HONGOS Antifungal Cream recalled for manufacturing practice deviations
CURA HONGOS Antifungal Cream (Clotrimazole 1%) is being recalled due to Current Good Manufacturing Practice deviations. The recall affects 10,788 tubes distributed in Delaware and North Carolina.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Classified as FDA Class II and initiated voluntarily by the manufacturer due to Current Good Manufacturing Practice deviations, this recall represents a precautionary measure with no reported adverse health events in the source material, aligning with Moderate severity per the rubric.
Plain-English summary
CURA HONGOS Antifungal Cream (Clotrimazole 1%, 2 oz tubes) manufactured by KENIL HEALTHCARE PRIVATE LIMITED is being recalled due to Current Good Manufacturing Practice (CGMP) deviations. The recall involves 10,788 tubes with lot number SP23A and expiration date March 31, 2026.
The affected product was distributed in Delaware and North Carolina through Pharmadel LLC. The recall was initiated voluntarily by the manufacturer on April 24, 2025.
Consumers who have obtained this product should stop using it and discard it properly, or contact the manufacturer or distributor for return instructions.
The recalled product
- Product
- CURA HONGOS, Antifungal Cream, Clotrimazole 1%, Net Wt/ Peso Neto 2 oz (56.7g) Tube, Distributed by: Pharmadel LLC, New Castle, DE 19720, Made in India, UPC 8 997110 011052.
- Manufacturer
- KENIL HEALTHCARE PRIVATE LIMITED
- Category
- Drug — Topical Antifungal
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot SP23A
- Exp Date: 03/31/2026
Distribution
Distributed in 2 states:
- DE
- NC
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27